Percent emphysema, airflow obstruction, and impaired left ventricular filling
- PMID: 20089972
- PMCID: PMC2887729
- DOI: 10.1056/NEJMoa0808836
Percent emphysema, airflow obstruction, and impaired left ventricular filling
Abstract
Background: Very severe chronic obstructive pulmonary disease causes cor pulmonale with elevated pulmonary vascular resistance and secondary reductions in left ventricular filling, stroke volume, and cardiac output. We hypothesized that emphysema, as detected on computed tomography (CT), and airflow obstruction are inversely related to left ventricular end-diastolic volume, stroke volume, and cardiac output among persons without very severe lung disease.
Methods: We measured left ventricular structure and function with the use of magnetic resonance imaging in 2816 persons who were 45 to 84 years of age. The extent of emphysema (expressed as percent emphysema) was defined as the percentage of voxels below -910 Hounsfield units in the lung windows on cardiac computed tomographic scans. Spirometry was performed according to American Thoracic Society guidelines. Generalized additive models were used to test for threshold effects.
Results: Of the study participants, 13% were current smokers, 38% were former smokers, and 49% had never smoked. A 10-point increase in percent emphysema was linearly related to reductions in left ventricular end-diastolic volume (-4.1 ml; 95% confidence interval [CI], -3.3 to -4.9; P<0.001), stroke volume (-2.7 ml; 95% CI, -2.2 to -3.3; P<0.001), and cardiac output (-0.19 liters per minute; 95% CI, -0.14 to -0.23; P<0.001). These associations were of greater magnitude among current smokers than among former smokers and those who had never smoked. The extent of airflow obstruction was similarly associated with left ventricular structure and function, and smoking status had similar modifying effects on these associations. Percent emphysema and airflow obstruction were not associated with the left ventricular ejection fraction.
Conclusions: In a population-based study, a greater extent of emphysema on CT scanning and more severe airflow obstruction were linearly related to impaired left ventricular filling, reduced stroke volume, and lower cardiac output without changes in the ejection fraction.
2010 Massachusetts Medical Society
Conflict of interest statement
Dr. Enright reports receiving consulting fees from Pfizer and Gilead; Dr. Hoffman, having equity ownership in and being a founder of VIDA Diagnostics and receiving lecture fees from Sanofi-Aventis, AstraZeneca, and Chiesi Pharmaceuticals; Dr. Kawut, receiving grant support from Pfizer; Dr. Lima, receiving grant support from Toshiba Medical Systems and General Electric; and Dr. Smith, receiving consulting fees from Merck and KarmelSonix. No other potential conflict of interest relevant to this article was reported.
Figures


Comment in
-
The shrinking heart in chronic obstructive pulmonary disease.N Engl J Med. 2010 Jan 21;362(3):267-8. doi: 10.1056/NEJMe0906251. N Engl J Med. 2010. PMID: 20089979 No abstract available.
-
Emphysema, airflow obstruction, and left ventricular filling.N Engl J Med. 2010 Apr 29;362(17):1638-9; author reply 1640-1. doi: 10.1056/NEJMc1002018. N Engl J Med. 2010. PMID: 20427814 No abstract available.
-
Emphysema, airflow obstruction, and left ventricular filling.N Engl J Med. 2010 Apr 29;362(17):1639-40; author reply 1640-1. N Engl J Med. 2010. PMID: 20437626 No abstract available.
-
Emphysema, airflow obstruction, and left ventricular filling.N Engl J Med. 2010 Apr 29;362(17):1639; author reply 1640-1. N Engl J Med. 2010. PMID: 20437627 No abstract available.
References
-
- Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55. - PubMed
-
- Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294:1255–9. - PubMed
-
- Celli BR, MacNee W ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–46. - PubMed
-
- Frank MJ, Weisse AB, Moschos CB, Levinson GE. Left ventricular function, metabolism and blood flow in chronic cor pulmonale. Circulation. 1973;47:798–806. - PubMed
-
- Steele P, Ellis JHJ, Van Dyke D, Sutton F, Creagh E, Davies H. Left ventricular ejection fraction in severe chronic obstructive airways disease. Am J Med. 1975;59:21–8. - PubMed
Publication types
MeSH terms
Grants and funding
- N01-HC95167/HC/NHLBI NIH HHS/United States
- ZIA CL090019/ImNIH/Intramural NIH HHS/United States
- N01-HC95161/HC/NHLBI NIH HHS/United States
- N01-HC95168/HC/NHLBI NIH HHS/United States
- R01 HL077612/HL/NHLBI NIH HHS/United States
- N01-HC95162/HC/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- N01-HC95160/HC/NHLBI NIH HHS/United States
- R01-HL077612/HL/NHLBI NIH HHS/United States
- N01-HC95169/HC/NHLBI NIH HHS/United States
- N01-HC95163/HC/NHLBI NIH HHS/United States
- N01-HC95166/HC/NHLBI NIH HHS/United States
- N01-HC95164/HC/NHLBI NIH HHS/United States
- ZIA EB000072/ImNIH/Intramural NIH HHS/United States
- R01-HL075476/HL/NHLBI NIH HHS/United States
- UL1-RR02415/RR/NCRR NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01-HC95165/HC/NHLBI NIH HHS/United States
- R01-HL093081/HL/NHLBI NIH HHS/United States
- R01 HL093081/HL/NHLBI NIH HHS/United States
- N01-HC95159/HC/NHLBI NIH HHS/United States
- Z99 CL999999/ImNIH/Intramural NIH HHS/United States
- R01 HL086719/HL/NHLBI NIH HHS/United States
- R01 HL075476/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Other Literature Sources
Medical